In the first quarter of 2022, the Chinese cosmetics company BOTANEE GROUP reached about $122 million of sales revenue, an increase of 59.32% year-on-year, with about $22.08 million of net profit attributable to shareholders of listed companies, an increase of 85.74% year-on-year. Founded in 2010, BOTANEE GROUP has several brands such as WINONA, BEAUTYANSWERS, DOU DOU KANG, Zirun and so on.
On April 27, Beijing time (the time of this article is Beijing time), China’s big health industry group BOTANEE GROUP released the first quarter report of 2022. During the reporting period, the company’s total revenue in the first quarter exceeded $122 million, an increase of 59.32% year-on-year, with a $22.08 million net profit attributable to the parent company, an increase of 85.74% year-on-year, with a $19 million of the non-net profit attributable to the parent company, an increase of 61.82% year-on-year and a $95 million of gross profit, an increase of 58.65% year-on-year.
Judging from the first-quarter financial report data of the past 3 years, BOTANEE GROUP has always maintained rapid growth in revenue and net profit. Especially in the first quarter of this year, BOTANEE GROUP’s net profit attributable to the parent company maintained a super high growth rate of more than 85%. It is mainly because the company put “WINONA” as the core and continues to innovate products so that brand awareness and customer trust are further improved, sales scale and sales revenue growth are relatively fast.
All along, BOTANEE GROUP has been based on the development strategy of “focusing on the main brand and expanding sub-brands”. In 2022, BOTANEE GROUP continued to focus on the main brand “WINONA” and consolidated its “soothing sensitive skins” series as the leading skincare product in China. Citing Euromonitor’s statistics, BOTANEE GROUP shows that WINONA ranks first in the Dermatological Skincare Products Chinese market, with a market share increase of about 2% in 2021 compared with 2020, with a significant effect.
In addition, BOTANEE GROUP has always regarded R&D innovation as the engine of enterprise development. In the first quarter of 2022, the R&D expenditure was $4.69 million, an increase of $1.23 million over the same period last year, an increase of about 35.71%. At present, BOTANEE GROUP has set up R & D centers in Shanghai and Kunming, and at the same time it set up a Yunnan characteristic plant extraction laboratory at the end of 2021, focusing on Yunnan characteristic plant industry, tackling core technologies, jointly building shared scientific research facilities, to realize the whole chain of transfer and transformation of scientific and technological achievements, an open first-class innovation and entrepreneurship ecology.
It is worth noting that BOTANEE GROUP’s net cash flow from operating activities in the first quarter was negative, down 429.12% from 2021 to negative $25 million. Among them, the cash outflow from operating activities in the first quarter was $161.86 million, an increase of about 70.41%.
This is mainly due to the combined impact of BOTANEE GROUP’s payment of procurement of means of production and production services by the supply chain plan, as well as the company’s targeted brand image promotion and continuous accurate investment in e-commerce channel expenses, as well as other increases in operating expenses.
As of 15:00 on April 28, 2022, BOTANEE GROUP was quoted at $30 per share, with a total market capitalization of $12.645 billion.
